» Articles » PMID: 34906475

Genetic Heterogeneity of Heritable Ectopic Mineralization Disorders in a Large International Cohort

Abstract

Purpose: Heritable ectopic mineralization disorders comprise a group of conditions with a broad range of clinical manifestations in nonskeletal connective tissues. We report the genetic findings from a large international cohort of 478 patients afflicted with ectopic mineralization.

Methods: Sequence variations were identified using a next-generation sequencing panel consisting of 29 genes reported in association with ectopic mineralization. The pathogenicity of select splicing and missense variants was analyzed in experimental systems in vitro and in vivo.

Results: A total of 872 variants of unknown significance as well as likely pathogenic and pathogenic variants were disclosed in 25 genes. A total of 159 distinct variants were identified in 425 patients in ABCC6, the gene responsible for pseudoxanthoma elasticum, a heritable multisystem ectopic mineralization disorder. The interpretation of variant pathogenicity relying on bioinformatic predictions did not provide a consensus. Our in vitro and in vivo functional assessment of 14 ABCC6 variants highlighted this dilemma and provided unambiguous interpretations to their pathogenicity.

Conclusion: The results expand the ABCC6 variant repertoire, shed new light on the genetic heterogeneity of heritable ectopic mineralization disorders, and provide evidence that functional characterization in appropriate experimental systems is necessary to determine the pathogenicity of genetic variants.

Citing Articles

Metabolites and metabolism in vascular calcification: links between adenosine signaling and the methionine cycle.

Behzadi P, St Hilaire C Am J Physiol Heart Circ Physiol. 2024; 327(6):H1361-H1375.

PMID: 39453431 PMC: 11588312. DOI: 10.1152/ajpheart.00267.2024.


Inorganic pyrophosphate plasma levels in patients with GGCX-associated PXE-like phenotypes.

Li Q, Troutman C, Peckiconis M, Wurst T, Terry S Front Genet. 2024; 15:1429320.

PMID: 39399214 PMC: 11466855. DOI: 10.3389/fgene.2024.1429320.


The pathogenic c.1171A>G (p.Arg391Gly) and c.2359G>A (p.Val787Ile) ABCC6 variants display incomplete penetrance causing pseudoxanthoma elasticum in a subset of individuals.

Szeri F, Miko A, Navasiolava N, Kaposi A, Verschuere S, Molnar B Hum Mutat. 2022; 43(12):1872-1881.

PMID: 36317459 PMC: 9772137. DOI: 10.1002/humu.24498.


ENPP1 variants in patients with GACI and PXE expand the clinical and genetic heterogeneity of heritable disorders of ectopic calcification.

Ralph D, Nitschke Y, Levine M, Caffet M, Wurst T, Saeidian A PLoS Genet. 2022; 18(4):e1010192.

PMID: 35482848 PMC: 9089899. DOI: 10.1371/journal.pgen.1010192.


Mutation update: Variants of the ENPP1 gene in pathologic calcification, hypophosphatemic rickets, and cutaneous hypopigmentation with punctate keratoderma.

Ralph D, Levine M, Richard G, Morrow M, Flynn E, Uitto J Hum Mutat. 2022; 43(9):1183-1200.

PMID: 35475527 PMC: 9357117. DOI: 10.1002/humu.24391.


References
1.
Huang J, Snook A, Uitto J, Li Q . Adenovirus-Mediated ABCC6 Gene Therapy for Heritable Ectopic Mineralization Disorders. J Invest Dermatol. 2019; 139(6):1254-1263. PMC: 6535136. DOI: 10.1016/j.jid.2018.12.017. View

2.
Belinsky M, Kruh G . MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver. Br J Cancer. 1999; 80(9):1342-9. PMC: 2363063. DOI: 10.1038/sj.bjc.6690527. View

3.
de Vasconcellos J, Zicari S, Fernicola S, Griffin D, Ji Y, Shin E . In vivo model of human post-traumatic heterotopic ossification demonstrates early fibroproliferative signature. J Transl Med. 2019; 17(1):248. PMC: 6679453. DOI: 10.1186/s12967-019-1996-y. View

4.
Topaz O, Indelman M, Chefetz I, Geiger D, Metzker A, Altschuler Y . A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis. Am J Hum Genet. 2006; 79(4):759-64. PMC: 1592555. DOI: 10.1086/508069. View

5.
Uitto J, Jiang Q, Varadi A, Bercovitch L, Terry S . PSEUDOXANTHOMA ELASTICUM: DIAGNOSTIC FEATURES, CLASSIFICATION, AND TREATMENT OPTIONS. Expert Opin Orphan Drugs. 2014; 2(6):567-577. PMC: 4219573. DOI: 10.1517/21678707.2014.908702. View